Biblio
Export 1713 results:
Author [ Title
Filters: First Letter Of Last Name is C [Clear All Filters]
“Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker.”, J Alzheimers Dis, vol. 49, no. 1, pp. 159-77, 2016.
, “Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker.”, J Alzheimers Dis, vol. 49, no. 1, pp. 159-77, 2016.
, “Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker.”, J Alzheimers Dis, vol. 49, no. 1, pp. 159-77, 2016.
, “Neuropathology of Anti-Amyloid-β Immunotherapy: A Case Report.”, J Alzheimers Dis, vol. 93, no. 2, pp. 803-813, 2023.
, “Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.”, J Alzheimers Dis, vol. 73, no. 1, pp. 333-345, 2020.
, “Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.”, J Alzheimers Dis, vol. 95, no. 1, pp. 307-316, 2023.
, “Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.”, J Alzheimers Dis, vol. 95, no. 1, pp. 307-316, 2023.
, “Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress.”, J Alzheimers Dis, vol. 71, no. 2, pp. 597-611, 2019.
, “Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress.”, J Alzheimers Dis, vol. 71, no. 2, pp. 597-611, 2019.
, “Neuronal activity regulates the regional vulnerability to amyloid-β deposition.”, Nat Neurosci, vol. 14, no. 6, pp. 750-6, 2011.
, “The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 3, pp. 741-754, 2024.
, “Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults.”, J Alzheimers Dis, vol. 28, no. 1, pp. 93-107, 2012.
, “Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations.”, J Alzheimers Dis, vol. 53, no. 1, pp. 303-13, 2016.
, “Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations.”, J Alzheimers Dis, vol. 53, no. 1, pp. 303-13, 2016.
, “NeuroEPO Preserves Neurons from Glutamate-Induced Excitotoxicity.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1469-1483, 2018.
, “Neurocognitive and Behavioral Indexes for Identifying the Amnestic Subtypes of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 2, pp. 633-649, 2017.
, “Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1641-52, 2016.
, “Neural Stem Cells in the Treatment of Alzheimer's Disease: Current Status, Challenges, and Future Prospects.”, J Alzheimers Dis, vol. 94, no. s1, pp. S173-S186, 2023.
, “Neural Correlates of Self-Reference Effect in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 2, pp. 717-731, 2017.
, “Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.”, J Alzheimers Dis, vol. 98, no. 3, pp. 793-823, 2024.
, “Network-Based Substrate of Cognitive Reserve in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 421-430, 2017.
, “Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 223-42, 2016.
, “Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 223-42, 2016.
, “Negative Prospective Memory in Alzheimer's Disease: "Do Not Perform That Action".”, J Alzheimers Dis, vol. 61, no. 2, pp. 663-672, 2018.
, “Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
,